Jad Khoraki1, Marilia G Moraes2, Adriana P F Neto2, Luke M Funk3, Jacob A Greenberg2, Guilherme M Campos4. 1. Division of General Surgery, Department of Surgery, University of Wisconsin, Madison, WI, United States; Division of Bariatric and Gastrointestinal Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, VA, United States. 2. Division of General Surgery, Department of Surgery, University of Wisconsin, Madison, WI, United States. 3. Division of General Surgery, Department of Surgery, University of Wisconsin, Madison, WI, United States; William S. Middleton Memorial Veterans Hospital, Madison, WI, United States. 4. Division of General Surgery, Department of Surgery, University of Wisconsin, Madison, WI, United States; Division of Bariatric and Gastrointestinal Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, VA, United States. Electronic address: guilherme.campos@vcuhealth.org.
Abstract
BACKGROUND: Laparoscopic adjustable gastric banding (LAGB) is an option for the treatment of severe obesity. Few US studies have reported long-term outcomes. We aimed to present long-term outcomes with LAGB. METHODS: Retrospective study of patients who underwent LAGB at an academic medical center in the US from 1/2005 to 2/2012. Outcomes included weight loss, complications, re-operations, and LAGB failure. RESULTS: 208 patients underwent LAGB. Mean BMI was 45.4 ± 6.4 kg/m2. Mean follow-up was 5.6 (0.5-10.7) years. Complete follow-up was available for 90% at one year (186/207), 80% at five years (136/171), and 71% at ten years (10/14). Percentage of excess weight loss at one, five, and ten years was 29.9, 30, and 16.9, respectively. Forty-eight patients (23.1%) required a reoperation. LAGB failure occurred in 118 (57%) and higher baseline BMI was the only independently associated factor (OR 1.1; 95%CI 1.0-1.1; p = 0.016). CONCLUSION: LAGB was associated with poor short and long-term weight loss outcomes and a high failure rate. With the increased safety profile and greater efficacy of other surgical techniques, LAGB utilization should be discouraged.
BACKGROUND: Laparoscopic adjustable gastric banding (LAGB) is an option for the treatment of severe obesity. Few US studies have reported long-term outcomes. We aimed to present long-term outcomes with LAGB. METHODS: Retrospective study of patients who underwent LAGB at an academic medical center in the US from 1/2005 to 2/2012. Outcomes included weight loss, complications, re-operations, and LAGB failure. RESULTS: 208 patients underwent LAGB. Mean BMI was 45.4 ± 6.4 kg/m2. Mean follow-up was 5.6 (0.5-10.7) years. Complete follow-up was available for 90% at one year (186/207), 80% at five years (136/171), and 71% at ten years (10/14). Percentage of excess weight loss at one, five, and ten years was 29.9, 30, and 16.9, respectively. Forty-eight patients (23.1%) required a reoperation. LAGB failure occurred in 118 (57%) and higher baseline BMI was the only independently associated factor (OR 1.1; 95%CI 1.0-1.1; p = 0.016). CONCLUSION: LAGB was associated with poor short and long-term weight loss outcomes and a high failure rate. With the increased safety profile and greater efficacy of other surgical techniques, LAGB utilization should be discouraged.
Authors: Marinka M G Koenis; Janet Ng; Beth Anderson; Michael C Stevens; Darren S Tishler; Pavlos K Papasavas; Andrea Stone; Tara McLaughlin; Allison Verhaak; Mirjana J Domakonda; Godfrey D Pearlson Journal: Front Hum Neurosci Date: 2022-08-25 Impact factor: 3.473